Home › NASDAQ: TLRY
Drug Manufacturers - Specialty & Generic
TLRY
2.24
Price1.32%   -0.03
pre-market Pre-market: 2.23 -0.01 -0.45%

Tilray, Inc. (TLRY)
loading

KEY STATS

Previous Close:
$2.27
Market Cap:
$1.62B
24h Volume:
16.73M
1D Range:
$2.20 - $2.31
52W Range:
$1.50 - $5.12
Primary Exchange:

COMPANY PROFILE

NameNameTilray, Inc.
sectorSectorHealthcare (1499)
industryIndustryDrug Manufacturers - Specialty & Generic (122)
webWebtilray.com
phonePhone844-845-7291
employeeEmployee241
twitter-icon Twitter @tilray
chart-line-icon Latest SEC Filings
twitter-icon TLRY's Discussions on Twitter
location1100 Maughan Road, Nanaimo, Canada (V9X IJ2)

UPGRADES & DOWNGRADES

Initiated Bernstein: Mkt Perform Nov-02-22
Downgrade The Benchmark Company: Hold → Sell Jul-29-22
Upgrade Canaccord Genuity: Hold → Buy Mar-04-22
Initiated Barclays: Underweight Nov-18-21
Downgrade Cantor Fitzgerald: Overweight → Neutral Nov-01-21
Downgrade CIBC: Sector Outperform → Neutral Jun-11-21
Upgrade Cantor Fitzgerald: Neutral → Overweight Jun-03-21
Resumed Cowen: Outperform May-11-21
Resumed Jefferies: Buy May-07-21
Initiated Canaccord Genuity: Buy May-06-21
Resumed BofA Securities: Buy Apr-28-21
Downgrade Piper Sandler: Overweight → Neutral Feb-18-21
Downgrade The Benchmark Company: Buy → Hold Feb-18-21
Downgrade Jefferies: Hold → Underperform Nov-16-20
Downgrade Stifel: Hold → Sell Nov-11-20
Reiterated MKM Partners: Neutral Oct-01-20
Upgrade Jefferies: Underperform → Hold Sep-21-20
Reiterated The Benchmark Company: Buy May-12-20
Downgrade Jefferies: Hold → Underperform Apr-16-20
Downgrade Consumer Edge Research: Overweight → Equal Weight Apr-09-20
Downgrade Cowen: Outperform → Market Perform Feb-24-20
Initiated BofA/Merrill: Neutral Jan-13-20
Reiterated The Benchmark Company: Buy Nov-13-19
Initiated Cantor Fitzgerald: Neutral Nov-05-19
Reiterated Piper Jaffray: Overweight Oct-22-19
Initiated MKM Partners: Neutral Sep-20-19
Reiterated The Benchmark Company: Buy Aug-14-19
Initiated Ladenburg Thalmann: Neutral Jul-17-19
Initiated Consumer Edge Research: Overweight Jun-28-19
Initiated Stifel: Hold Jun-06-19
Initiated Oppenheimer: Perform Jun-05-19
Upgrade BMO Capital Markets: Underperform → Market Perform May-15-19
Initiated Alliance Global Partners: Neutral May-13-19
More Upgrades & Downgrades
News Price History Option Chain Financials Insider Trading Why TLRY Down? Discussions Forecast Stock Split Dividend History

Tilray, Inc. Stock (TLRY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Debt to Equity Ratio

loading

About Tilray, Inc.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.
Open in Yahoo | Open in Google | Open in Finviz
Cap:     |  Volume (24h):